Wettig Thane bought FGEN
November 13, 2025 · Form 4 insider transaction
Wettig Thane bought 1,000 shares of FibroGen Incorporated at $9.18 per share, a transaction worth $9.2K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,000
Price
$9.18
Total value
$9.2K
InsiderWettig Thane
RoleOfficer, Director
CompanyFibroGen Incorporated (FGEN)
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateNovember 13, 2025
Filing dateNovember 17, 2025
Shares owned after22,239
OwnershipDirect
10b5-1 planNo
AmendedNo